Skip to content

Contact us
Newsroom
- Our locations
  
  Australia
  
  Austria
  
  Belgium nl fr
  
  China
  
  Czech Republic
  
  Denmark
  
  Estonia
  
  Finland fi en
  
  France
  
  Germany
  
  Greece
  
  Hungary
  
  India
  
  Ireland
  
  Italy
  
  Japan
  
  Kazakhstan ru kz
  
  Latvia
  
  Lithuania
  
  Malaysia
  
  Netherlands
  
  Norway
  
  Poland
  
  Singapore
  
  Slovenia
  
  Spain
  
  Sweden
  
  Switzerland
  
  Thailand
  
  UK
  
  Ukraine
Visit global site 

What are you looking for?

Quick links

Careers at Orion

About Orion Pharma
To main page of

About Orion Pharma
Science & Innovation
To main page of

Science & Innovation
Therapy areas
To main page of

Therapy areas
Partnering
To main page of

Partnering
Investors
To main page of

Investors
Careers
To main page of

Careers

About Orion Pharma
Science & Innovation
Therapy areas
Partnering
Investors
Careers
Contact us
Newsroom

Orion as an investment

Orion as an investment

Orion Pharma 2025 highlights
Orion as an investment
- Strategy: The road is open for growth through well-being
Reports and presentations
Financial information
Shares
Shareholders
Corporate Governance
IR Calendar
Investor Relations

Start page  Investors  Reports and presentations  Capital Markets Days  Capital Markets Day 2025

Orion as an investment

Orion as an investment

Orion Pharma 2025 highlights
Orion as an investment
- Strategy: The road is open for growth through well-being
Reports and presentations
Financial information
Shares
Shareholders
Corporate Governance
IR Calendar
Investor Relations

Capital Markets Day 2025

Orion arranged Capital Markets Day in Helsinki on 22 May 2025.

Previous Capital Markets Days

WATCH THE WEBCAST

Presentations

Orion CMD 2025 (all presentations)
Liisa Hurme, President & CEO
Outi Vaarala, EVP Innovative Medicines and Research & Development
Hao Pan, EVP Branded Products
Satu Ahomäki, EVP Generics and Consumer Health
Niclas Lindstedt, EVP Animal Health
René Lindell, CFO

About us
Science
Therapy areas
Products
Partnering
Investors
Careers
Contact us

Orion Corporation, Orionintie 1A, 02200 Espoo.
PO Box 65, FI-02101 Espoo, Finland
Phone +358 10 4261

© Copyright Orion Corporation. Company code, VAT 19992126

About us
Science
Therapy areas
Products
Partnering
Investors
Careers at Orion

Contact us
Newsroom
Orion Pharma brand

Privacy
Site terms
Cookie Policy